Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Services
  3. netherlands
  4. therapy for prostate cancer
Show results for
Products
Services
Applications

Companies


Refine by
Locations
Back to All Locations

  • Europe
  • Netherlands

Therapy For Prostate Cancer Services In Netherlands

4 services found
In NetherlandsAvailable In NetherlandsNear Netherlands

Epitope Selection & Validation Service

Epitope Selection & Validation Service

Manufactured by:Sanquin   based inAmsterdam, NETHERLANDS
Our proprietary technology for UV-induced MHC-peptide exchange is ideally suited for high-throughput screening of peptide-binding to the MHC class I complexes. Moreover, combinatorial coding enables fast finding of relevant peptide-specific cytotoxic T ...
CONTACT SUPPLIER

Immuno-Oncology

Immuno-Oncology

Manufactured by:Kiadis Pharma NV   based inAmsterdam, NETHERLANDS
Innovative antibody-based molecular concepts. New treatments for cancer that leverage our own immune system to attack and destroy cancer cells can provide long-term and durable therapeutic responses in patients suffering from life-threatening malignancies. These benefits for patients have been driven by recently developed therapeutic antibodies binding with high specificity to drug targets on ...
CONTACT SUPPLIER

Lymphatic Surgery

Lymphatic Surgery

Manufactured by:Microsure B.V.   based inSon, NETHERLANDS
LVA or lymph node reconstruction for various indications. The use of a dedicated robot for microsurgery in treating breast cancer-related lymphedema. Women with breast cancer are often treated with (partial) breast and axillary tissue resection and radiotherapy. As survival from cancer continues to improve, greater importance is placed on quality of life after surgery. In about 20% of the women ...
CONTACT SUPPLIER

Prostate Cancer Treatment

Prostate Cancer Treatment

Manufactured by:Soteria Medical BV   based inArnhem, NETHERLANDS
Prostate cancer is the most common cancer, other than non-melanoma skin cancer, and the second leading cause of cancer-related death in men in the United States. Prostate cancer incidence rates rose dramatically in the late 1980s, when screening with the prostate-specific antigen (PSA) test, which received initial U.S. Food and Drug Administration approval in 1986, came into wide use. It is ...
CONTACT SUPPLIER
  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT